indolactam v has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, DE; Dos Santos, JL; Lopes, JR | 1 |
| Ahmed, S; Curreli, F; Debnath, AK; Victor, SMB | 1 |
1 review(s) available for indolactam v and HIV Coinfection
| Article | Year |
|---|---|
HIV latency reversal agents: A potential path for functional cure?
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Molecular Structure; Virus Latency | 2021 |
1 other study(ies) available for indolactam v and HIV Coinfection
| Article | Year |
|---|---|
Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV.
Topics: CD4-Positive T-Lymphocytes; Drug Synergism; Enzyme Activation; Enzyme Activators; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Indoles; Lactams; Phenylbutyrates; Phorbol Esters; Protein Kinase C; Virus Activation; Virus Latency | 2020 |